Wednesday, April 16, 2025
Home Tags DYAI

Tag: DYAI

2020 Watch List

Committed to Win. C-1 and Dyadic’s (DYAI) Drive to Make Vaccines...

Editor / Curator -
Dyadic, Biotech Stock Review
2020 Watch List

Dyadic (DYAI) Price Target $12.

Editor / Curator -
Biotech News

Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double...

Editor / Curator -
Dyadic
Biotech News

Could Dyadic (DYAI) $5.75 Provide a Solution to Help Mass Produce...

Editor / Curator -
Immunomedics, Biotech Stock Review
All News

Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in...

Editor / Curator -
biogen, biotech stock review
Biotech News

Biotech’s Turning Up…

Editor / Curator -
Dyadic, Biotech Stock Review
Biotech News

Dyadic (DYAI) Highlights.

Editor / Curator -
Dyadic, Biotech Stock Review
Biotech News

Dyadic (DYAI) $7.00 Called a ‘Gamechanger’ – Gets $14 Price Target.

Editor / Curator -
Dyadic
Biotech News

Investor Presentation Slides From Dyadic (DYA) $6.40.

Editor / Curator -
biotech stock review, dyadic
All News

Must Watch Video: Dyadic’s (DYAI) Matthew Jones.

Editor / Curator -
12Page 1 of 2

Latest article

GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.

2025 Watch List Editor / Curator -
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...

Adding Allarity (ALLR) $0.70, to Watch List.

2025 Watch List Editor / Curator -
LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...

Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!

2025 Watch List Editor / Curator -
This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36. We last added Bavarian to...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.